Modeling for Prediction of Mortality Based on past Medical History in Hospitalized COVID-19 Patients: A Secondary Analysis by Seyyed Amir Yasin Ahmadi, Yeganeh Karimi, Arash Abdollahi, Ali Kabir

“…Considering the prevalence of underlying diseases, many mortality cases of COVID-19 are attributable to the history of cardiovascular disease. Future studies are needed for policy making regarding reduction of COVID-19 mortality in susceptible groups in the post-COVID-19 era.…”
Get full text

Deep Learning for Predicting Spheroid Viability: Novel Convolutional Neural Network Model for Automating Quality Control for Three-Dimensional Bioprinting by Zyva A. Sheikh, Oliver Clarke, Amatullah Mir, Narutoshi Hibino

“…This deep-learning model offers a non-invasive, efficient, and accurate method to streamline the assessment of spheroid quality, thereby accelerating the development of bioengineered cardiac tissue patches for cardiovascular disease therapies.…”
Get full text

Investigation of Homocysteine-Pathway-Related Variants in Essential Hypertension by Javed Y. Fowdar, Marta V. Lason, Attila L. Szvetko, Rodney A. Lea, Lyn R. Griffiths

“…Hyperhomocysteinemia (hHcy) has been associated with an increased risk of cardiovascular disease and stroke. Essential hypertension (EH), a polygenic condition, has also been associated with increased risk of cardiovascular related disorders. …”
Get full text

Comparing imputation approaches to handle systematically missing inputs in risk calculators. by Anja Mühlemann, Philip Stange, Antoine Faul, Serena Lozza-Fiacco, Rowan Iskandar, Manuela Moraru, Susanne Theis, Petra Stute, Ben D Spycher, David Ginsbourger

“…To illustrate this, we use the SCORE2 risk calculator for cardiovascular disease and a data set including medical data from 359 women, obtained from the gynecology department at the Inselspital in Bern, Switzerland. …”
Get full text

Nano-technological advancements in multimodal diagnosis and treatment by Dinesh Bhatia, Tania Acharjee, Shruti Shukla, Monika Bhatia

“…This nanotechnology-based technique personalizes medicines for diseases such as tuberculosis (TB) and cardiovascular disease (CVD), focusing on damaged tissues to improve therapeutic response. …”
Get full text

Identification of Genetic Biomarkers for Diagnosis of Myocardial Infarction Compared with Angina Patients by Yuanyuan Zhang, Chunyang Tian, Xuejian Liu, He Zhang

“…Myocardial infarction (MI) is the most terrible appearance of cardiovascular disease. The incidence of heart failure, one of the complications of MI, has increased in the past few decades. …”
Get full text

The implementation of a system of CardioQVARK to personalize treatment in terms of the digital ecosystem healthcare formation by V. Isaenko, M. Rybina

“…This team feels as its goal system implementation into the daily life of the person a tool for early diagnosis of cardiovascular disease and all possible risks associated with this disease, including factors leading to the development of tuberculosis. …”
Get full text

TMAO-Activated Hepatocyte-Derived Exosomes Are Widely Distributed in Mice with Different Patterns and Promote Vascular Inflammation by Xiang Liu, Jiazichao Tu, Ziqin Zhou, Bingxin Huang, Jianrong Zhou, Jimei Chen

“…Trimethylamine-N-oxide (TMAO) has been shown to be an important player in cardiovascular disease (CVD) by promoting vascular inflammation and endothelial dysfunction. …”
Get full text

Challenges in Initiating Antiretroviral Therapy in 2010 by Cécile L Tremblay, Jean-Guy Baril, David Fletcher, Donald Kilby, Paul MacPherson, Stephen D Shafran, Mark W Tyndall

“…While effective at combating HIV, ART can produce adverse alterations of lipid parameters, with some studies suggesting a relationship between some anti-retroviral agents and cardiovascular disease. As the HIV-positive population ages, issues such as hypertension and diabetes must be taken into account when initiating ART. …”
Get full text

Prevalence of metabolic syndrome and its risk factors among the government bank’s employees of district Bijnor, Uttar Pradesh: A cross-sectional study by Ajay Kumar Prajapati, Ruchi Prajapati

“…Background: Metabolic syndrome (MetS) involves having at least 3 out of 5 health conditions that increase the risk of cardiovascular disease, stroke, and type 2 diabetes mellitus. …”
Get full text

The Role of Clopidogrel in 2020: A Reappraisal by Giuseppe Patti, Giuseppe Micieli, Claudio Cimminiello, Leonardo Bolognese

“…Antiplatelet therapy is the mainstay of treatment and secondary prevention of cardiovascular disease (CVD), including acute coronary syndrome (ACS), transient ischemic attack (TIA) or minor stroke, and peripheral artery disease (PAD). …”
Get full text

Developing Targeted Health Service Interventions Using the PRECEDE-PROCEED Model: Two Australian Case Studies by Jane L. Phillips, John X. Rolley, Patricia M. Davidson

“…Using a reflective case study approach, this paper examines the applicability of the PRECEDE-PROCEED Model to the development of targeted chronic care improvement interventions for two distinct Australian populations: a rapidly expanding and aging rural population with unmet palliative care needs and a disadvantaged urban community at higher risk of cardiovascular disease. Results. The PRECEDE-PROCEED Model approach demonstrated utility across diverse health settings in a systematic planning process. …”
Get full text

Optimizing RNA extraction methods for high-throughput transcriptome sequencing of formalin-fixed paraffin-embedded cardiac tissue specimens. by Nkechi Martina Odogwu, Jin Sung Jang, Sabrina Albertson, Clinton Hagen, Boyd Rasmussen, Oommen Saji, Timothy J Nelson, Wanek Program Preclinical Pipeline

“…Archived FFPE cardiac tissue specimens are valuable for molecular studies aimed at identifying biomarkers linked to mortality in cardiovascular disease. Establishing a reliable and reproducible RNA extraction method is critical for generating high-quality transcriptome sequences for molecular assays. …”
Get full text

Ficolin B in Diabetic Kidney Disease in a Mouse Model of Type 1 Diabetes by Charlotte Berg Holt, Jakob Appel Østergaard, Esben Axelgaard, Gitte Krogh Nielsen, Yuichi Endo, Steffen Thiel, Troels Krarup Hansen

“…The innate immune system may have adverse effects in diabetes and cardiovascular disease. The complement system seems to play a key role through erroneous complement activation via hyperglycaemia-induced neoepitopes. …”
Get full text

Stress and arterial hypertension: ISIAH rat strain by Ye. V. Antonov, Yu. V. Alexandrovich, A. A. Seryapina, L. O. Klimov, A. L. Markel

“…It is well known that stress is one of the major risk factors for cardiovascular disease development. Increase in blood pressure is a typical manifestation of the acute stress response. …”
Get full text

The Increasing Financial Impact of Chronic Kidney Disease in Australia by Patrick S. Tucker, Michael I. Kingsley, R. Hugh Morton, Aaron T. Scanlan, Vincent J. Dalbo

“…The aim of this investigation was to determine and compare current and projected expenditure associated with chronic kidney disease (CKD), renal replacement therapy (RRT), and cardiovascular disease (CVD) in Australia. Data published by Australia and New Zealand Dialysis and Transplant Registry, Australian Institute of Health and Welfare, and World Bank were used to compare CKD-, RRT-, and CVD-related expenditure and prevalence rates. …”
Get full text

Metabolic Syndrome and Its Associated Factors among Type 2 Diabetic Patients in Southwest Ethiopia, 2021/2022 by Dereje Gemeda, Endegena Abebe, Abdissa Duguma

“…There is a 5-fold increase in metabolic syndrome associated with type 2 diabetes and a 2-fold increase associated with the development of cardiovascular disease. The calorie-dense diet and sedentary life patterns are the most important contributory factors that have been established. …”
Get full text

Recent advances in immunotherapy targeting CETP proteins for atherosclerosis prevention by Wenhui Hu, Han Feng, Ying Liu, Xiaoshuang Xu, Ping Zhou, Zhonghua Sun, Xinyu Tao, Jiahui Yang, Jun Wu, Chen Qu, Zhengxia Liu

“…CETP inhibitors, such as obicetrapib, represent a novel approach in immunotherapy to reduce the risk of atherosclerotic cardiovascular disease (ASCVD) by targeting lipid metabolism. …”
Get full text

The association between underlying conditions, risk factors, risk markers, and post-COVID conditions ≥6 months after COVID-19: A systematic review by Aisha Hill, Madelon Morford, Sharon Saydah, Pamela Logan, Danielle Raso, Erin C. Stone, Joanna Taliano, Emilia H. Koumans, Olga Varechtchouk

“…Underlying conditions, including COPD/lung disease, overweight status or obesity, hypertension, cardiovascular disease, and asthma, were identified as possibly being associated with an increased risk of post-COVID symptoms. …”
Get full text

Combination drug therapy prevents CIAKI by suppressing ER stress-induced apoptosis by Xuan Wang, Shan Han, Lili Zhao, Hongliang Cong

Get full text